This inventor holds 1 USPTO granted patent. Top assignee: Sami Labs Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Kalyanam Nagabushnam: Innovator in Anti-Inflammatory Treatments
Introduction
Kalyanam Nagabushnam is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory treatments. His work focuses on innovative chemical compounds that target inflammatory diseases.
Latest Patents
Kalyanam holds 1 patent for his invention titled "Chemical entities with multiple modes of anti-inflammatory action." This patent relates to methods of treatment and pharmaceutical compositions of new chemical compounds that inhibit various enzymes in the arachidonic acid pathway, which are implicated in inflammatory disease conditions.
Career Highlights
Kalyanam Nagabushnam is associated with Sami Labs Limited, where he continues to advance research in pharmaceutical innovations. His expertise in chemical entities has positioned him as a key figure in the development of effective treatments for inflammatory diseases.
Collaborations
He has collaborated with notable professionals in his field, including Muhammed Majeed and Rajendran Ramanujam. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Kalyanam Nagabushnam's contributions to anti-inflammatory treatments through his innovative patents and collaborations highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments for inflammatory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile